RhumbLine Advisers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.52M Buy
65,556
+2,017
+3% +$139K ﹤0.01% 1464
2025
Q1
$4.41M Buy
63,539
+5,898
+10% +$410K ﹤0.01% 1421
2024
Q4
$4.96M Sell
57,641
-5,598
-9% -$482K ﹤0.01% 1427
2024
Q3
$7.53M Buy
63,239
+2,265
+4% +$270K 0.01% 1204
2024
Q2
$8.7M Buy
60,974
+270
+0.4% +$38.5K 0.01% 1096
2024
Q1
$7.79M Buy
60,704
+1,851
+3% +$238K 0.01% 1171
2023
Q4
$6.09M Sell
58,853
-469
-0.8% -$48.5K 0.01% 1302
2023
Q3
$5.39M Buy
59,322
+5,780
+11% +$526K 0.01% 1288
2023
Q2
$4.33M Buy
+53,542
New +$4.33M ﹤0.01% 1463
2021
Q4
Sell
-4,180
Closed -$201K 3018
2021
Q3
$201K Buy
+4,180
New +$201K ﹤0.01% 2914
2016
Q3
Sell
-41,600
Closed -$1.12M 2916
2016
Q2
$1.12M Hold
41,600
﹤0.01% 1714
2016
Q1
$1.13M Hold
41,600
﹤0.01% 1715
2015
Q4
$1.21M Buy
41,600
+2,200
+6% +$63.9K ﹤0.01% 1686
2015
Q3
$1.07M Buy
39,400
+1,200
+3% +$32.6K ﹤0.01% 1721
2015
Q2
$1.05M Sell
38,200
-14,800
-28% -$405K ﹤0.01% 1836
2015
Q1
$1.42M Sell
53,000
-200
-0.4% -$5.34K ﹤0.01% 1647
2014
Q4
$1.13M Sell
53,200
-6,600
-11% -$140K ﹤0.01% 1721
2014
Q3
$1.42M Hold
59,800
﹤0.01% 1535
2014
Q2
$1.38M Hold
59,800
﹤0.01% 1621
2014
Q1
$1.37M Sell
59,800
-1,000
-2% -$22.8K ﹤0.01% 1599
2013
Q4
$1.12M Buy
60,800
+33,000
+119% +$610K ﹤0.01% 1735
2013
Q3
$470K Buy
27,800
+10,000
+56% +$169K ﹤0.01% 2249
2013
Q2
$276K Buy
+17,800
New +$276K ﹤0.01% 2720